Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$6.10+0.22 (+3.74%)
Close on Nov 13, 2026Market cap $114.13MP/E –Yield –
Trinity Biotech operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -36.1%, against -34.4% the year before. The highest annual figure on record is 13.5% in fiscal 2015.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -36.1% | −1.7 |
| FY2024 | Dec 31, 2024 | -34.4% | +13.2 |
| FY2023 | Dec 31, 2023 | -47.6% | −16.6 |
| FY2022 | Dec 31, 2022 | -30.9% | −35.8 |
| FY2021 | Dec 31, 2021 | 4.9% | +4.8 |
| FY2020 | Dec 31, 2020 | 0.1% | +26.7 |
| FY2019 | Dec 31, 2019 | -26.7% | −5.8 |
| FY2018 | Dec 31, 2018 | -20.8% | +17.1 |
| FY2017 | Dec 31, 2017 | -38.0% | +2.0 |
| FY2016 | Dec 31, 2016 | -40.0% | −53.5 |
| FY2015 | Dec 31, 2015 | 13.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | 6.9% | – |
| Q2 FY2017 | Jun 30, 2017 | 7.2% | – |
See a number that looks wrong?